See every side of every news story
Published loading...Updated

Nimbus Synergies Bolsters Health Tech Leadership with Strategic Board Appointments - Life Sciences British Columbia

Summary by lifesciencesbc.ca
Nimbus Synergies, a venture capital firm investing in companies using technology to improve outcomes, increase efficiencies, and lower costs in healthcare, is pleased to announce the appointment of Wendy Hurlburt and Bree Stanlake to its Board of Directors. These appointments mark a pivotal step in Nimbus’ evolution to become Canada’s leading health technology venture investment platform. “We’re thrilled to welcome Wendy and Bree to our Board,”…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

lifesciencesbc.ca broke the news in on Monday, March 31, 2025.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.